Síndrome de DRESS asociado a Levetiracetam

Síndrome de DRESS asociado a Levetiracetam

El síndrome de DRESS es una toxicodermia asociada a eosinofilia con síntomas sistémicos. Presentamos un caso de dicho síndrome tras inicio de Levetiracetam con buena evolución tras inicio de corticoides y retirada del fármaco. Este síndrome, poco conocido y probablemente infradiagnosticado, puede...

Full description

Bibliographic Details
Main Authors:	Moreno Díaz J, Martínez Huguet C, Arazo Garcés P
Format:	Article
Language:	English
Published:	Sociedade Galega de Medicina Interna 2016-09-01
Series:	Galicia Clínica
Subjects:	Fiebre Rash Eosinofilia Levetiracetam
Online Access:	http://www.galiciaclinica.info/PDF/37/874.pdf

Similar Items

DRESS syndrome associated to the use of anticonvulsant medications
by: Antonio Belaunde Clausell, et al.
Published: (2020-08-01)

Levetiracetam-induced drug reaction: violaceous discrete maculopapular rash: A case report
by: Arvinpreet Kour, et al.
Published: (2023-01-01)

Sindrome de reacción a medicamento con eosinofilia y síntomas sistémicos (DRESS) asociado a levetiracetam: reporte de caso.
by: Elliot Barreto-Acevedo, et al.
Published: (2022-09-01)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
by: Opeyemi Samson Osuntokun, et al.
Published: (2021-01-01)

Levetiracetam induced rhabdomyolysis
by: Anthony C. Torres, et al.
Published: (2021-01-01)

Manifestaciones articulares de la fiebre Chikungunya
by: Andrés Zúñiga Vera, et al.
Published: (2022-04-01)

Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking phenytoin and levetiracetam: a case report
by: Hall David Jeffrey, et al.
Published: (2013-01-01)

Caso clínico: sindrome de DRESS por hidroxicloroquina
by: yosahandi estefania pacheco jimenez, et al.
Published: (2023-08-01)

Stuttering Priapism Associated with Levetiracetam
by: Mehmet Taylan PEKÖZ, et al.
Published: (2018-08-01)

Síndrome DRESS causado por alopurinol y desencadenado por COVID-19
by: Telma Elias, et al.
Published: (2000-10-01)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01)

Hallucination: A rare complication of levetiracetam theraphy
by: Seher Erdogan, et al.
Published: (2017-11-01)

A case of glossopharyngeal neuralgia successfully treated with levetiracetam
by: Hiroyuki Nishie, et al.
Published: (2023-02-01)

Reacción a medicamentos con eosinofilia y síntomas sistémicos: Síndrome DRESS, reporte de un caso
by: Hipólito Guillermo Escobar Palma, et al.
Published: (2021-05-01)

Phenytoin Versus Levetiracetam for Post-traumatic Seizure Prophylaxis
by: Tuğçe Mengi, et al.
Published: (2022-12-01)

Levetiracetam induced behavioral changes: a case report
by: R. Kamalraj, et al.
Published: (2018-12-01)

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
by: Chanin Clark Wright, et al.
Published: (2013-12-01)

PNEUMONIA EOSINOFÍLICA E PROVÁVEL SÍNDROME DE CHURG-STRAUSS: UM RELATO DE CASO
by: Alícia Regina Zambiasi, et al.
Published: (2023-09-01)

PNEUMONIA EOSINOFÍLICA E PROVÁVEL SÍNDROME DE CHURG-STRAUSS: UM RELATO DE CASO
by: Alícia Regina Zambiasi, et al.
Published: (2023-09-01)

Levetiracetam versus phenytoin in children with status epilepticus
by: Gowhar Wani, et al.
Published: (2019-01-01)

Efficacy of levetiracetam for neonatal seizures in preterm infants
by: Ji Yoon Han, et al.
Published: (2018-04-01)

Miocardiopatía Restrictiva secundaria a Síndrome Hipereosinofílico
by: Ana Margarita Jerez Castro, et al.
Published: (2017-04-01)

Síndrome de eosinofília pulmonar presentación clínica y serie de casos
by: N Egea, et al.
Published: (2014-02-01)

Síndrome Hipereosinofílico.
by: Sheila Wiesner, et al.
Published: (2022-09-01)

Efficacy of Levetiracetam Monotherapy in Childhood Epilepsy
by: Müjgan ARSLAN, et al.
Published: (2017-04-01)

Therapeutic drug monitoring of levetiracetam in newborns
by: Irina B. Bondareva, et al.
Published: (2019-12-01)

Teratogenic Effect of Keppra (Levetiracetam) Drug on the Kidney in Albino Rat (Rattus rattus)
by: Lamyaa H. M. Al-Ibrahimi., et al.
Published: (2017-03-01)

Umbilical Cord, Maternal Milk, and Breastfed Infant Levetiracetam Concentrations Monitoring at Delivery and during Early Postpartum Period
by: Ivana Kacirova, et al.
Published: (2021-03-01)

Relationship of levetiracetam and obsessive-compulsive disorder: a case report
by: Fikret Poyraz Çökmüş, et al.
Published: (2017-07-01)

Effect of levetiracetam and valproate on late-onset post-traumatic seizures
by: Yanli Wang, et al.
Published: (2023-04-01)

TICS IN CHILDREN. CLINICAL RESULT OF THE TREATMENT TIC DISORDERS BY LEVETIRACETAM
by: Ju. V. Borodina, et al.
Published: (2016-05-01)

Restless Legs Syndrome in Patients with Epilepsy Under Levetiracetam Monotherapy
by: Gülnihal Kutlu, et al.
Published: (2018-03-01)

Teratogenic Effect of Levetiracetam Drug on the Development of the Kidney in Embryo Rat
by: Lamyaa H. M. Al-Ibrahimi, et al.
Published: (2018-04-01)

Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01)

Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01)

A case of rhabdomyolysis in which levetiracetam was suspected as the cause
by: Hisanao Akiyama, et al.
Published: (2014-01-01)

Intravenous levetiracetam in critically ill children
by: Faruk Incecik, et al.
Published: (2016-01-01)

Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients
by: Rui Silva, et al.
Published: (2022-08-01)

Levetiracetam effectiveness as add-on therapy in Bulgarian patients with drug-resistant epilepsy
by: Ekaterina I. Viteva, et al.
Published: (2021-04-01)

Mechanisms of levetiracetam in the control of status epilepticus and epilepsy
by: Laxmikant S Deshpande, et al.
Published: (2014-01-01)